Literature DB >> 15778115

HIV and cancer of the cervix.

Z M Chirenje1.   

Abstract

Cancer of the cervix is the second most common cause of cancer-related death in women worldwide, and in some low resource countries accounts for the highest cancer mortality in women. The highest burden of the HIV/AIDS epidemic is currently in sub-Saharan Africa, where more than half of the people infected are women who have no access to cervical cancer screening. The association between HIV and invasive cervical cancer is complex, with several studies now clearly demonstrating an increased risk of pre-invasive cervical lesions among HIV-infected women. However, there have not been significantly higher incidence rates of invasive cervical cancer associated with the HIV epidemic. The highest numbers of HIV-infected women are in poorly-resourced countries, where the natural progression of HIV disease in the absence of highly active antiretroviral treatment sometimes results in deaths from opportunistic infections before the onset of invasive cervical cancer. This chapter will discuss the association of HIV and cervical intraepithelial neoplasia, the treatment of pre-invasive lesions, and invasive cervical cancer in HIV-infected women. The role of screening and the impact of antiretroviral treatment on the progression of pre-invasive and invasive cancer will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778115     DOI: 10.1016/j.bpobgyn.2004.10.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  32 in total

1.  Surgical pathology in sub-Saharan Africa--volunteering in Malawi.

Authors:  Sabina Berezowska; Tamiwe Tomoka; Steve Kamiza; Danny A Milner; Rupert Langer
Journal:  Virchows Arch       Date:  2012-03-10       Impact factor: 4.064

2.  Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya.

Authors:  Hillary Mabeya; Kareem Khozaim; Tao Liu; Omenge Orango; David Chumba; Latha Pisharodi; Jane Carter; Susan Cu-Uvin
Journal:  J Low Genit Tract Dis       Date:  2012-04       Impact factor: 1.925

Review 3.  HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?

Authors:  Emily P Hyle; Kogieleum Naidoo; Amanda E Su; Wafaa M El-Sadr; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

4.  Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.

Authors:  Washington Mudini; Joel M Palefsky; Martin J Hale; Michael Z Chirenje; Rudo Makunike-Mutasa; Fiona Mutisi; Alltalents Murahwa; Altini Mario
Journal:  J Acquir Immune Defic Syndr       Date:  2018-09-01       Impact factor: 3.731

5.  Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya.

Authors:  Chemtai Mungo; Craig R Cohen; May Maloba; Elizabeth A Bukusi; Megan J Huchko
Journal:  Int J Gynaecol Obstet       Date:  2013-09-10       Impact factor: 3.561

6.  Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.

Authors:  Sharon Kapambwe; Vikrant V Sahasrabuddhe; Meridith Blevins; Mulindi H Mwanahamuntu; Victor Mudenda; Bryan E Shepherd; Carla J Chibwesha; Krista S Pfaendler; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

7.  Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda.

Authors:  Stephen Asiimwe; Christopher C Whalen; Daniel J Tisch; Elioda Tumwesigye; Ajay K Sethi
Journal:  Int J STD AIDS       Date:  2008-09       Impact factor: 1.359

8.  Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.

Authors:  Krista S Pfaendler; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Victor Mudenda; Jeffrey S A Stringer; Groesbeck P Parham
Journal:  Gynecol Oncol       Date:  2008-06-16       Impact factor: 5.482

9.  Expression of HLA-I, CD8, and CD4 and Their Clinical Significance in Cervical Cancer.

Authors:  Jiang Tao Fan; Yan Liao; Xiao Hui Si; Xiao Li Geng; Wei Wei; Qing Li Xie
Journal:  World J Oncol       Date:  2011-02-26

10.  Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.

Authors:  Marina Munoz; Milena Camargo; Sara C Soto-De Leon; Ricardo Sanchez; Diana Parra; Andrea C Pineda; Otto Sussmann; Antonio Perez-Prados; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.